W. Meline David's Insider Trades & SAST Disclosures
W. Meline David's most recent trade in Pacific Biosciences of California Inc was a trade of 24,134 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern W. Meline David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | David W. Meline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,134 | 24,134 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | David W. Meline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 17,116 | 57,116 (0%) | 0% | 0 | Common Stock | |
| HP Inc | David W. Meline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2024 | 7,943 | 10,690 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | David W. Meline | Director | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 06 Mar 2024 | 40,000 | 40,000 (0%) | 0% | 4.4 | 176,160 | Common Stock |
| HP Inc | David W. Meline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2023 | 2,747 | 2,747 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | W. Meline David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 86,954 | 86,954 | - | - | Stock Option (right to buy) | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 348 | 3,482 | - | - | Restricted Stock Units | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 348 | 3,021 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 173.66 per share. | 09 Aug 2022 | 164 | 2,857 (0%) | 0% | 173.7 | 28,481 | Common Stock |
| Moderna Inc | David W. Meline | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 26,020 | 26,020 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 6,415 | 6,415 | - | - | Restricted Stock Units | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 1,392 | 4,178 | - | - | Restricted Stock Units | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 1,392 | 3,010 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 158.89 per share. | 09 Feb 2022 | 619 | 2,391 (0%) | 0% | 158.9 | 98,354 | Common Stock |
| Moderna Inc | David W. Meline | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 25,618 | 25,618 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | David W. Meline | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 5,570 | 5,570 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges